Physician profile
Brian D Steffin
NPI 1568571248
$5,382.49
in general payments reported to CMS, 2019-2025
8 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2022: $1,371 · 2023: $2,182 · 2024: $94.50 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,555 · Food and Beverage: $1,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,555.36 |
| Food and Beverage | $1,467.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,042.77 | 2019-2025 | Rosa, Avenir, Persona |
| Stryker Corporation | $1,922.51 | 2019-2025 | Mako |
| Depuy Synthes Sales INC. | $185.09 | 2023-2025 | Na, Velys, Actis |
| Smith+Nephew, INC. | $87.36 | 2025 | Real Intelligence |
| Pacira Pharmaceuticals Incorporated | $69.36 | 2023-2025 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $39.38 | 2025 | Xcell |
| Becton, Dickinson and Company | $20.79 | 2025 | Channel Drain |
| Heraeus Medical, LLC. | $15.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Steffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.